CDC Reports Illnesses from Contaminated Glutathione Injections Across Four States
More than 25 people in four states became ill after receiving glutathione injections, with at least three hospitalized. The CDC said the injections were compounded with dietary supplement-grade glutathione, which is not safe for sterile injectable use due to contamination risk. Several pharmacies have recalled products, and the FDA issued a safety alert.
The CDC traced the illnesses to compounding pharmacies that used glutathione labeled for dietary supplements, not sterile injectables. Endotoxin contamination—bacterial byproducts that trigger severe immune reactions—was confirmed in recalled lots, with symptoms including fever, chills, and dangerous drops in blood pressure. One patient required intensive care for shock and clotting abnormalities.
Recalls have expanded beyond the initial four states, with products distributed nationwide via home delivery. The FDA notes no approved injectable glutathione exists, and past outbreaks in Australia and the U.S. underscore recurring risks from unregulated compounding practices.
This incident could heighten scrutiny of compounding pharmacies and wellness clinics offering unapproved injectable treatments. Patients seeking cosmetic or energy-boosting therapies may face serious harm, while regulators may tighten oversight of ingredient sourcing. Public trust in alternative medicine could erode, though legitimate compounding remains vital for many prescriptions. The case count may rise as reporting continues.